We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Premaitha | LSE:NIPT | London | Ordinary Share | GB00BN31ZD89 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 9.10 | 9.00 | 9.20 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
23/9/2016 10:47 | Holding RNS out. Now we know who has been soaking up any sells ! | brainspark1 | |
23/9/2016 10:43 | We shall find out next week....... only thing for certain is one of us will be right and one of us will be wrong | sh1984 | |
23/9/2016 10:08 | Why the need for the additional £4m if there's £5m in the bank ? In truth we don't know yet but given that Premaitha have not exactly been forthcoming with detailed info I'd err on the side of caution until we know for definite. | gooosed | |
23/9/2016 09:59 | The Shuffle Man You don't need an invite to join ShareSoc the web site is about to have a total overhaul and that is one of the glitches which will be addressed (I believe) You can apply here, there is a very modest annual subscription, but remember it is a not for profit organisation run by small shareholders like ourselves for the benefit of small shareholders and it would not exist if it were not for subscriptions and volunteers. | timbo003 | |
23/9/2016 09:46 | Goosed.. how can it be inclusive of the £4m loan?? it hasn't been drawn yet? | sh1984 | |
23/9/2016 09:42 | I expect it will be! | hjb1 | |
23/9/2016 09:42 | Timbo How do you get an invitation to join sharesoc ? | the shuffle man | |
23/9/2016 09:38 | "sh1984 22 Sep '16 - 08:20 - 3660 of 3672 0 0 That's quite impressive if they still have £5m cash in the bank, given costs must have gone up with organic business growth, implies the sales figures must be 200% up from last year? " I wonder if that £5m is inclusive of the additional £4m TF loan - if so then not quite so impressive ?! | gooosed | |
23/9/2016 09:23 | That's a nice vote of confidence from Thermo Fisher and would appear to lessen the chance of any dilutive fund raise in the short term. I'll get a few notes out on the Sharesoc meeting later today, meanwhile the slide set used is now available on the ShareSoc web site: | timbo003 | |
23/9/2016 09:10 | Take step back, increased provisions, additional borrowings, no material sales contract... | tsmith2 | |
23/9/2016 09:08 | Dr Stephen Little, CEO, commented: "The additional investment by Thermo Fisher, together with the Company's existing liquid resources, enables Premaitha to mount the strongest legal defence against Illumina, while at the same time accelerating complementary product development - such as the validation of the IONA(R) test on Thermo Fisher's ION S5(TM) range of instruments. Validating the IONA(R) test on the S5 instruments will better align the Company with Thermo Fisher's distribution channels, allowing Premaitha to offer broader availability of the IONA(R) test in territories outside of Europe. The additional funds will therefore allow Premaitha to continue to invest in building its international commercial capabilities." | brainspark1 | |
23/9/2016 09:06 | Well done Premaitha! Added again. | brainspark1 | |
23/9/2016 09:01 | Extra £4m will go a long way.............. | sh1984 | |
23/9/2016 09:01 | Excellent news, another Thermo Fisher agreement. All guns loaded on illumina | brainspark1 | |
23/9/2016 08:59 | Quietly on a Friday.. | tsmith2 | |
23/9/2016 08:59 | Profits warning.Also, can that really be called an investment? It's a loan, isn't it? | tsmith2 | |
22/9/2016 09:40 | He said within a few days, so end this week or early next, if that helps! The other little nugget was cancer test, oncology. He mentioned in passing and I asked for more detail, did they have their own IP in this area? He said they were not a research company, they would expect to licence the IP and suggested they were in talks. I got the impression they were very much focused on the Nipt test and legal case first but very much the impression that there is a substantive plan on the oncology side. | 62rick | |
22/9/2016 08:31 | Definitely, market capital should be around the £50m mark which is twice current share price value............... did the CEO say when results are out? can't be any later than end of next week anyway due to legal reasons. | sh1984 | |
22/9/2016 08:27 | Agreed sh1984, if that is the case.....I expect the share price to be closer to 20p than 10p. Interesting times | brainspark1 | |
22/9/2016 08:20 | That's quite impressive if they still have £5m cash in the bank, given costs must have gone up with organic business growth, implies the sales figures must be 200% up from last year? | sh1984 | |
22/9/2016 07:48 | Over on LSE "Hi Paduardo, don't forget the cash! The CEO said that they still have about £5 million cash (down from £6.3 previously). This is pretty encouraging, I was expecting cash to be much lower now, so suggests either sales are performing well or they haven't paid anyone for six months." No results today but the CEO tells attendees how much cash left in the business which points to good sales. Not via proper channels, but this is AIM | brainspark1 | |
22/9/2016 06:30 | Thanks timbo003, Look forward to reading your write-up. I think it will likely be overshadowed by Prelims which I expect today. aimho | twix386 | |
22/9/2016 00:21 | I'll endeavour to write something up on tonight's ShareSoc presentation on Thursday, but it won't be until afternoon/evening (at the earliest) as I have an AGM to attend in the morning. | timbo003 | |
21/9/2016 23:44 | Aye. 5 pence more like | the monkster |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions